1
Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy
Condition(s):Effects of ImmunotherapyLast Updated:December 20, 2022Completed
Immunotherapy: 6637 Clinical Trials, Page 1 of 664
Hide Studies Not Open or Pending
2
Oral Immunotherapy in Young Children With Food Allergy
Condition(s):Food AllergyLast Updated:February 22, 2023Enrolling by invitation
3
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
Condition(s):Immunotherapy; Lung CancerLast Updated:February 27, 2020Recruiting
4
Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial
Condition(s):Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) HNSCCLast Updated:February 17, 2023Active, not recruiting
5
CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
Condition(s):EphA2 Positive Malignant Glioma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
6
A Preliminary Study About Unexplained Recurrent Miscarriage and Repeated Implantation Failure Patients Treated With Low-dose Lymphocyte Immunotherapy
Condition(s):Unexplained Recurrent Miscarriage and Recurrent Implantation FailureLast Updated:April 11, 2018Completed
7
Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma
Condition(s):Urinary Bladder NeoplasmLast Updated:December 1, 2021Terminated
8
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients
Condition(s):GD2 Positive Glioma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
9
Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy
Condition(s):Locally Advanced Non Small Cell Lung Cancer; Metastatic Non Small Cell Lung CancerLast Updated:February 21, 2023Recruiting
10
CAR-T Cell Immunotherapy for HCC Targeting GPC3
Condition(s):GPC3 Positive Hepatocellular Carcinoma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn